1. Home
  2. CDNA vs MFA Comparison

CDNA vs MFA Comparison

Compare CDNA & MFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$19.46

Market Cap

712.2M

Sector

Health Care

ML Signal

HOLD

Logo MFA Financial Inc.

MFA

MFA Financial Inc.

HOLD

Current Price

$9.55

Market Cap

976.0M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDNA
MFA
Founded
1998
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
712.2M
976.0M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
CDNA
MFA
Price
$19.46
$9.55
Analyst Decision
Buy
Buy
Analyst Count
7
7
Target Price
$26.00
$10.96
AVG Volume (30 Days)
816.3K
1.1M
Earning Date
11-04-2025
11-06-2025
Dividend Yield
N/A
15.00%
EPS Growth
N/A
N/A
EPS
1.22
0.86
Revenue
$357,998,000.00
$279,011,000.00
Revenue This Year
$14.11
N/A
Revenue Next Year
$12.00
$14.85
P/E Ratio
$16.92
$11.17
Revenue Growth
14.46
N/A
52 Week Low
$10.96
$7.85
52 Week High
$25.95
$11.08

Technical Indicators

Market Signals
Indicator
CDNA
MFA
Relative Strength Index (RSI) 60.65 55.39
Support Level $18.36 $9.45
Resistance Level $20.92 $9.72
Average True Range (ATR) 0.88 0.13
MACD 0.08 0.00
Stochastic Oscillator 59.45 35.85

Price Performance

Historical Comparison
CDNA
MFA

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About MFA MFA Financial Inc.

MFA Financial Inc is a specialty finance company that invests in and finances residential mortgage assets. Its principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. The company selectively invests in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return. The company's reportable segments include mortgage-related assets and Lima One.

Share on Social Networks: